iRhythm Appoints New President and CEO
Posted on August 7, 2012 @ 01:18 pm
Medical device service company iRhythm Technologies Inc.’s board of directors has appointed Kevin King to succeed Bill Willis as president, CEO and board member. King brings nearly three decades of experience in successive corporate leadership roles.
Willis will be assisting with the transition.
King noted that there is “significant opportunity for rapid expansion,” for the company.
King most recently served as president and CEO of Affymetrix, where led a new growth strategy into the multi-billion dollar market for downstream validation and molecular diagnostics. Previously, King was president and CEO of Thomson Healthcare, an information services business focused on a range of healthcare-related information services businesses. King has also held leadership roles at GE Healthcare, where he led the several-fold increase of the clinical systems business. He also held key leadership positions within Hewlett Packard's Medical Products Group including in research and development, sales, marketing and business development.
King earned his bachelor’s from the University of Massachusetts and an MBA from New Hampshire College.
iRhythm provides diagnostic monitoring solutions that facilitate early diagnosis and treatment decisions, with the goal of ultimately improving patient health outcomes and reducing wasteful healthcare spending. Its flagship product, the Zio Patch, is designed to optimize and simplify the diagnosis of cardiac arrhythmias. The company is based in San Francisco, Calif.
Please visit our sister sites:
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.